Alpha-fetoprotein (AFP) IVD, antibody
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen, using a chemiluminescent immunoassay method.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen.
A material which is used to establish known points of reference for an assay intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen, using a radioimmunoassay method.
A collection of reagents and other associated materials intended to qualitatively and/or quantitatively detect alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen using a fluorescent immunoassay method.
A material used to verify the performance of an assay intended to qualitatively and/or quantitatively detect alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen.
A material used to establish known points of reference for an assay intended to qualitatively and/or quantitatively detect alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen, using a fluorescent immunoassay method.
A biochemical agent intended to be used with a parent IVD to perform a specific function in an assay used to qualitatively and/or quantitatively detect alpha-fetoprotein-L3 fraction (AFP-L3) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen, using an enzyme immunoassay (EIA) method.
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of alpha-fetoprotein (AFP) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the quantitative measurement of multiple hormone levels in a clinical specimen using an enzyme immunoassay (EIA) method, in order to predict the risk of trisomy 21 (Down syndrom...
A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of multiple hormone levels in a clinical specimen, in order to predict the risk of trisomy 21 (Down syndrome) as part of a first or second tr...
A collection of reagents and other associated materials intended to be used for the quantitative measurement of multiple hormone levels in a clinical specimen using a chemiluminescent immunoassay method, in order to predict the risk of trisomy 21 (Down synd...